Advanced
Product
Solutions
Partners
Resources
Company
Toggle menu
Home
/
GV20 Oncotherapy
GV20 Oncotherapy
Overview
Locations
Financials
Operating Metrics
Human Capital
Key People
Competitors
Supplier Risk
GV20 Oncotherapy
GV20 Oncotherapy Summary
Company Summary
Overview
GV20 Oncotherapy is a company developing biotechnologies and drugs against cancer. It offers gene editing and bioinformatics technologies to find targets for treating cancer.
Type
Private
Status
Active
Founded
2016
HQ
Cambridge, MA, US
|
view all locations
Website
https://gv20oncotherapy.com/
Cybersecurity rating
Sectors
Technology
artificial intelligence
biotech
drug development
healthtech
pharma
Homepage
Linkedin
Table of Contents
Key People
Locations
Competitors
Key People
Ted Xiao,
Chief Technology Officer, Co-Founder
Linkedin
Sherlock H,
Chief Information Officer
Linkedin
Wei Yang,
Chief Scientific Officer
Steve Landau,
Chief of Development
Locations
View all
2 locations detected
Cambridge, MA
HQ
United States
One Broadway, 14th floor, Kendall Square
Shanghai, Shanghai Shi
China
801, 781 Cailun Rd, Pudong Xinqu
Competitors and Similar Companies
BERG
Technology - Private
Novadiscovery
Technology - Private
Wren Therapeutics
Healthcare - Private
Pepticom
Healthcare - Private
Compare competitors
Footer menu
Contact us
Product
Intelligence Suite
Supplier Intelligence Platform
Craft Intelligence Portal
Craft API
Craft for Teams
Supplier Intelligence Platform
Craft Alerts
Craft N-Tier Mapping
Craft Risk Hub
Chrome extension
Solutions
Supplier Intelligence
Sales Intelligence
Aerospace and Defense
Resources
Resource center
Blog
Company
About
Careers
Contact
Terms of Service
Privacy Policy
Security
© Craft.co 2026
Share price data provided by IEX
Back
to top